top of page

Catching up with the co-founders of Amylyx on the launch of their ALS treatment

Josh Cohen and Justin Klee provide an update on the launch of RELYVRIO, discuss the PHOENIX P3 trial, and reflect on the roller coaster of the last year.



Commentaires


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page